-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$2.38 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$22.47 M
Olema Pharmaceuticals, Inc. Insider Transactions
Olema Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Harmon Cyrus
Director |
Sell | 25,000 @ $12.41 | $310,250 | 973,714 | 09/29/2023 | 10/03/2023 | |
|
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF |
Sell | 20,000 @ $12.67 | $253,400 | 572,011 | 09/19/2023 | 09/21/2023 | |
|
Graham G. Walmsley
Director |
Buy | 508,130 @ $9.84 | $5.00 M | 1,668,130 | 09/12/2023 | 12/18/2023 | |
|
BVF PARTNERS L P/IL
Director, 10 percent owner: |
Buy | 775,278 @ $9.84 | $7.63 M | 4,688,954 | 09/12/2023 | 09/14/2023 | |
|
BVF PARTNERS L P/IL
Director, 10 percent owner: |
Buy | 677,853 @ $9.84 | $6.67 M | 3,584,512 | 09/12/2023 | 09/14/2023 | |
|
BVF PARTNERS L P/IL
Director, 10 percent owner: |
Buy | 52,801 @ $9.84 | $519,562 | 524,151 | 09/12/2023 | 09/14/2023 | |
|
Harmon Cyrus
Director |
Sell | 10,000 @ $11.62 | $116,200 | 998,714 | 09/05/2023 | 09/05/2023 | |
|
Harmon Cyrus
Director |
Sell | 15,000 @ $9.36 | $140,400 | 1,008,714 | 08/31/2023 | 09/05/2023 | |
|
Harmon Cyrus
Director |
Sell | 15,000 @ $10.14 | $152,100 | 1,023,714 | 08/16/2023 | 08/17/2023 | |
|
Harmon Cyrus
Director |
Sell | 10,000 @ $6.30 | $63,000 | 1,038,714 | 06/08/2023 | 06/09/2023 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $6.30 | $31,475 | 1,048,714 | 06/06/2023 | 06/07/2023 | |
|
Harmon Cyrus
Director |
Sell | 5,000 @ $6.05 | $30,225 | 1,053,714 | 06/05/2023 | 06/07/2023 | |
|
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF. |
Buy | 10,000 @ $3.42 | $34,173 | 396,197 | 04/06/2023 | 04/07/2023 |
Olema Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Olema Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Olema Pharmaceuticals, Inc. includes Myles David C., Harmon Cyrus, Kovacs Shane William Charles, Bohen Sean, Zojwalla Naseem, Graham G. Walmsley, Paradigm Biocapital Advisors LP.
-
How much insider selling is happening at Olema Pharmaceuticals, Inc.?
Insiders have sold a total of 1.57 M Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 22.47 M sold.
-
Which Olema Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Olema Pharmaceuticals, Inc. shares in the last 12 months: Myles David C. ($613,961), Harmon Cyrus ($3.10 M), Kovacs Shane William Charles ($269,656), Bohen Sean ($824,134), Zojwalla Naseem ($209,296), Graham G. Walmsley ($17.45 M),
-
How much insider buying is happening at Olema Pharmaceuticals, Inc.?
Insiders have purchased a total of 181,870 Olema Pharmaceuticals, Inc. shares in the last 12 months for a total of 2.38 M sold.
-
Which Olema Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased Olema Pharmaceuticals, Inc. shares in the last 12 months: Graham G. Walmsley ($1.22 M), Paradigm Biocapital Advisors LP ($1.16 M),